Retatrutide

Retatrutide – Triple GLP-1 / GIP / Glucagon Receptor Agonist

Retatrutide is a next-generation triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. It represents the cutting edge of metabolic peptide research, with studies investigating its superior efficacy in weight regulation and energy expenditure compared to single and dual agonists.

Research Applications

• Triple receptor agonism studies (GLP-1, GIP, glucagon)
• Advanced obesity and metabolic disorder research
• Energy expenditure and thermogenesis investigation
• Comparative studies vs. Semaglutide and Tirzepatide

Purity & Testing

Every batch is independently tested by Janoshik Analytical Laboratories. Certificate of Analysis (COA) available for download on this page.

Molecular Weight: ~4.8 kDa | Class: Acylated peptide triple agonist

⚠ Research Use Only: This product is strictly for laboratory and research purposes. Not for human consumption. Must be handled by qualified researchers in accordance with applicable regulations.